These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Varenicline: the French experience after 6 months. Prescrire Int; 2009 Feb; 18(99):25. PubMed ID: 19396936 [No Abstract] [Full Text] [Related]
3. Exacerbation of recurrent depression as a result of treatment with varenicline. Popkin MK Am J Psychiatry; 2008 Jun; 165(6):774. PubMed ID: 18519539 [No Abstract] [Full Text] [Related]
4. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation. Kistler CE; Goldstein AO Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928 [No Abstract] [Full Text] [Related]
5. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline]. Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682 [No Abstract] [Full Text] [Related]
6. Varenicline (Chantix) for tobacco dependence. Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281 [No Abstract] [Full Text] [Related]
7. A case of late-life onset mania during Varenicline assisted smoking cessation. Francois D; Odom A; Kotbi N Int J Geriatr Psychiatry; 2011 Jun; 26(6):658-9. PubMed ID: 21480382 [No Abstract] [Full Text] [Related]
8. In brief: Cardiovascular safety of varenicline (Chantix). Med Lett Drugs Ther; 2011 Aug; 53(1371):65. PubMed ID: 21860367 [No Abstract] [Full Text] [Related]
10. Hallucinations in the context of varenicline withdrawal. Laine P; Marttila J; Lindeman S Am J Psychiatry; 2009 May; 166(5):619-20. PubMed ID: 19411384 [No Abstract] [Full Text] [Related]
11. Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events. O'Malley P Clin Nurse Spec; 2009; 23(1):13-5. PubMed ID: 19098509 [No Abstract] [Full Text] [Related]
12. [New drugs; varenicline]. van Bronswijk H; Dubois EA; Zitman FG; Cohen AF Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of varenicline for smoking cessation. Hays JT; Ebbert JO; Sood A Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165 [TBL] [Abstract][Full Text] [Related]
18. New reports examine psychiatric risks of varenicline for smoking cessation. Kuehn BM JAMA; 2012 Jan; 307(2):129-30. PubMed ID: 22235073 [No Abstract] [Full Text] [Related]
19. Varenicline and the evaluation of neuropsychiatric adverse events in smokers. O'Malley SS Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436 [No Abstract] [Full Text] [Related]
20. Practical implementation of varenicline as an aid to smoking cessation in clinical practice. Tonstad S Pneumologia; 2009; 58(3):167-74. PubMed ID: 19817313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]